When: |
20 Sep through 22 Sep 2018 | |
Where: |
Le Grand-Saconnex, Switzerland | |
Website URL: |
https://go.evvnt.com/219939-0?pid=4868 | |
Sponsoring organization: |
EASL The Home of Hepatology | |
Categories: |
Medicine & Health - Pharmaceutical / Medicinal |
Keywords:
Event description:
NAFLD has become a leading cause of chronic liver disease globally given the rise in levels of obesity and type 2 diabetes mellitus. It presents unique challenges to the liver community given the complex multi-factorial origins of obesity and the metabolic syndrome and also the presence of multiple co-morbidities in many patients with NAFLD. There also remain many challenges such as the identification of at-risk individuals, the development of lifestyle and pharmacological therapies and ultimately the assessment of their cost-effectiveness.
This summit will cover the whole spectrum of basic and translational/clinical aspects of NAFLD, including views from patients groups and the latest advances in new therapeutic developments.
Unlike other NAFLD meetings, this summit will also feature multiple case conferences exploring the key issues in the management of patients, with keynote speakers providing the evidence to support decision making resulting in a series of consensus statem...
Read more
Posting date:
15 May 2018 | 146 views
Placement:
Not-featured (How do I make my event featured?)
Flag (Report this event)